ClinicalTrials.gg
Drug

Brimonidine clinical trials

Also written Alphagan and Mirvaso.

studies test it
104
open now
5
in phase 3
26
first study started
1998

Counted the way a researcher would: Brimonidine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses brimonidine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the brimonidine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
6 Sept 1996 · ALPHAGAN · NDA 020613 (FDA, Drugs@FDA)
European Union
20 Feb 2014 · Mirvaso · EMEA/H/C/002642 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Brimonidine
20
Brimonidine Tartrate
13
Alphagan® P
6
Brimonidine Tartrate PS DDS®
5
COMBIGAN®
5

Brand

Alphagan
11
Mirvaso
5
Lumify
3

Development codes

OCU-310
1
CD07805/47
1
OCU-300
1
AGN-190342
1

In one entry with another drug

Given together, or one or the other

carbachol/brimonidine tartrate
3
bimatoprost/brimonidine tartrate/timolol ophthalmic solution (Triple Combination Therapy)
2

Studies by the year they started

99 studies that test it; most in 2016 (11); 1 more planned to start later

Studies that test brimonidine, by start year
YearStudies
19981
19991
20033
20041
20055
20064
20088
20097
20106
20118
20124
20132
20146
20151
201611
20173
20184
20196
20201
20213
20227
20231
20241
20254
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
7
Phase 2
23
Phase 3
26
Phase 4
32
No phase
15

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 49 · Other 55

Allergan (17) · Galderma R&D (9) · Bausch & Lomb Incorporated (7) · Visus Therapeutics (3) · Wake Forest University Health Sciences (3) · Ocugen (3) · Massachusetts Eye and Ear Infirmary (3) · Eye Therapies, LLC (3)

Often tested with

Tested in the same studies.

Timolol (10) · Dorzolamide (6) · Latanoprost (5) · Carbachol (3) · Bimatoprost (3) · Acetazolamide (3) · Brinzolamide (3) · Travoprost (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test brimonidine.

Studies

Open first, then newest update. How each study uses brimonidine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 104

See all 104 studies that test brimonidine →

Given beside what is tested · 7 — brimonidine is usual care or a partner of the new treatment
As the comparator · 9 — what is tested is compared with brimonidine

What changed recently

From the registry's own updates since Oct 18, 2026.

Started recruiting1

Codes

What other systems call brimonidine · ClinicalTrials.gg INT006513

  • MeSH (NLM) D000068438Brimonidine TartrateConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) E6GNX3HHTEBRIMONIDINEConfirmed FDA, NLM, Wikidata
  • RxNorm 134615Confirmed FDA, Wikidata
  • Wikidata Q577377brimonidineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C65269BrimonidineOne source FDA
  • DrugBank DB00484One source Wikidata

Also registered as brimonidine tartrate (UNII 4S9CL2DY2H · RxNorm 39171).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.